BioCis Pharma Ltd
Quick facts
Phase 2 pipeline
- Cis-UCA 2.5% emulsion cream · Dermatology
Cis-UCA 2.5% emulsion cream is a topical treatment that works by reducing inflammation and modulating the immune response. - Cis-UCA 5% emulsion cream · Dermatology
Cis-UCA 5% emulsion cream is a topical treatment that works by reducing inflammation and modulating the immune response. - Protopic® 0.1% ointment
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: